InvestorsHub Logo
icon url

CTMedic

03/05/21 9:41 PM

#150358 RE: Maverick0408 #150354

Maverick,

Aviptadil trial (relief therapeutics) patients had increased mortality at 28 days.

Subsequent analysis indicated that there may be benefit achieved at 42 and 60 days.